Dec 09 2019 0 Breakthrough lupus drug discovered in Edmonton passes final testing phase [Global News] https://globalnews.ca/news/6273515/lupus-drug-edmonton-discovery/
Aug 09 2019 1 Research institute launched out of U of A attracts $25 million in investments [Edmonton Journal] https://edmontonjournal.com/business/local-business/research-institute-launched-out-of-u-of-a-attracts-25-million-in-investments
Aug 02 2019 2 https://hepionpharma.com/wp-content/uploads/2019/08/Final.mp4 Introduction to Hepion Pharmaceuticals By Hepion | Media Placements | No Comments Read More
Aug 01 2019 2 Hepion Pharmaceuticals’ CEO Robert Foster discusses CRV431’s potential in NASH [BioTuesdays] https://www.biotuesdays.com/features/2019/7/30/hepion-pharmaceuticals-ceo-robert-foster-discusses-crv431s-potential-in-nash
Nov 13 2018 1 Robert Foster swinging for the fence again with Hepion Pharma [BioTuesdays] http://www.biotuesdays.com/features/2018/11/7/robert-foster-swinging-for-the-fence-again-with-contravir-pharma
Mar 02 2017 0 TXL for hepatitis B safe, effective in phase 2a study [via Healio] http://www.healio.com/hepatology/viral-hepatitis/news/online/%7B16ae8488-4b93-459f-94b1-197f2dd77d75%7D/txl-for-hepatitis-b-safe-effective-in-phase-2a-study
Oct 26 2016 0 An Update on Hepatitis B Therapies [Drug Discovery World] http://www.ddw-online.com/fall-2016/p315872-an-update-on-hepatitis-b-therapies.html
Oct 14 2016 1 Dr. Robert Foster, Chief Scientific Officer of Hepion, invited to join the Faculty of Pharmacy & Pharmaceutical Sciences at the University of Alberta as an Honorary Professor https://hepionpharma.com/wp-content/uploads/2016/07/RTF-Professorship.pdf
Oct 11 2016 0 The Rise of the CFO Strategist: Balancing Numbers and Know-how [Via PharmaExec] http://www.pharmexec.com/rise-cfo-strategist-balancing-numbers-and-know-how
Jul 25 2016 0 Hepion Hopes To Establish Backbone For Hepatitis B Combo Therapy [via Scrip] https://scrip.pharmamedtechbi.com/SC096933/Hepion-Hopes-To-Establish-Backbone-For-Hepatitis-B-Combo-Therapy
